Stock Watch: The Pandemic Still Permeates Through Q3 Earnings
In Addition To Currency And Capacity Issues
While big tech is suffering from a return to normality after the pandemic, big pharma always had a recovery in its base business to return to. But after the third-quarter earnings season, it seems both base and pandemic pharmaceutical businesses are still co-existing for now.
